Anqing Municipal Hospital   Report issue

Academic/Hospital Phase 3
Founded: Anqing China (1938)

Organization Overview

First Clinical Trial
2016
NCT02736552
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Anqing Municipal Hospital | Department of Anqing Hospital Anesthesiology | Xu Siqi

Active Ingredients

Drugs in Phase 3 Trials (4)

gimeracil (1 trial)

oteracil (1 trial)

s-1 (1 trial)

tegafur (1 trial)

Drugs in Other Trials (3)

dexmedetomidine (precedex) (5 trials)

esketamine (spravato) (1 trial)

lidocaine (xylocaine) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 7